References

Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent – a population based study from the DAHANCA group

10.1016/j.radonc.2016.02.006 · 2016 · External reference

Early-stage glottic squamous cell carcinoma: a Nationwide analysis on incidence, survival, recurrences, and laryngectomies after radiotherapy in the Netherlands (2015–2021)

10.1002/hed.70245 · 2026 · External reference

Risk of dysfunctional larynx after radiotherapy for early-stage glottic laryngeal cancer: a systematic review and meta-analysis

2025 · External reference

Stereotactic ablative radiotherapy for T1 to T2 glottic larynx cancer: mature results from the phase 2 GLoTtic larynx-SABR trial

10.1016/j.ijrobp.2024.07.2147 · 2025 · External reference

Stereotactic radiation therapy in 3 fractions for T1 glottic Cancer

10.1016/j.ijrobp.2024.09.051 · 2025 · External reference

Ultra-Hypofractionated radiotherapy for early-stage glottic Cancer: real-world data from a single Center

10.1002/hed.28139 · 2025 · External reference

Early closure of a phase 1 clinical trial for SABR in early-stage glottic cancer

10.1016/j.ijrobp.2019.03.011 · 2019 · External reference

Phase 1 fractional dose-escalation study of equipotent stereotactic radiation therapy regimens for early-stage glottic larynx cancer

10.1016/j.ijrobp.2019.03.010 · 2019 · External reference

The impact of treatment time and smoking on local control and complications in T1 glottic cancer

10.1016/s0360-3016(98)00226-0 · 1998 · External reference

Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists

2025 · External reference

Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac

2021 · External reference

The voice handicap index (VHI)

10.1044/1058-0360.0603.66 · 1997 · External reference